MedCPU Obtains $35,000,000 Series E Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab4f52d6-ec09-4701-86a2-62d3b60989ae - Date
2/29/2016 - Company Name
MedCPU - Mailing Address
100 Wall Street New York, NY 10005 USA - Company Description
MedCPU was created by physicians with over 17 years experience in introducing clinical decision support technologies into the high acuity clinical settings. We understand the pressures of today’s healthcare environment, and the deficiencies of healthcare IT that may increase the challenges clinicians are facing. - Website
http://www.medcpu.com - Transaction Type
Venture Equity - Transaction Amount
$35,000,000 - Transaction Round
Series E - Proceeds Purposes
Our partnership with medCPU will provide UPMC with technology and solutions that will be immediately valuable to our clinicians and patients. Longer term, this powerful technology will enable the development of other data-dependent applications in such critical areas as care management, population health and consumer engagement. - M&A Terms
- Venture Investor
UPMC Health Plan - Venture Investor
Merck Global Health Innovation Fund
